Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti-RNA Polymerase III Autoantibodies-Reference-Cited by-同舟云学术

Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti-RNA Polymerase III Autoantibodies

Published:2015-03-27 Issue:4 Volume:67 Page:1045-1052
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Hamaguchi Yasuhito¹,Kodera Masanari²,Matsushita Takashi¹,Hasegawa Minoru¹,Inaba Yuki²,Usuda Toshikazu²,Kuwana Masataka³,Takehara Kazuhiko¹,Fujimoto Manabu⁴

Affiliation:

1. Kanazawa University; Kanazawa Japan

2. Social Insurance Chukyo Hospital; Nagoya Japan

3. Keio University School of Medicine; Tokyo Japan

4. Kanazawa University, Kanazawa, Japan, and University of Tsukuba; Tsukuba Japan

Funder

the Ministry of Health, Labor and Welfare of Japan

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference33 articles.

1. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology;Tan;Adv Immunol,1989

2. Antinuclear antibody in systemic sclerosis (scleroderma);Okano;Rheum Dis Clin North Am,1996

3. Renal manifestations of systemic sclerosis-clinical features and outcome assessment;Denton;Rheumatology (Oxford),2008

4. Factors predicting development of renal involvement in progressive systemic sclerosis;Steen;Am J Med,1984

5. Long-term outcomes of scleroderma renal crisis;Steen;Ann Intern Med,2000

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Disorders in Systemic Sclerosis: A Comprehensive Review;Journal of Clinical Medicine;2024-01-11

2. The Clinical Aspects of Autoantibodies;Scleroderma;2024

3. Renal Crisis and Other Renal Manifestations;Scleroderma;2024

4. The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity;International Journal of Molecular Sciences;2023-09-19

5. Approach to Systemic Sclerosis Patient Assessment;Rheumatic Disease Clinics of North America;2023-05